Surrozen, Inc. Warrant (SRZNW)
Company News
Surrozen Reports Q2 Profit on Gains
Biotechnology company Surrozen reported a surprising Q2 2025 net income of $39.7 million, driven primarily by non-cash gains, while continuing to advance its ophthalmology pipeline focused on Wnt pathway modulation.